You can dust those other patent’s down now Marc.
OPDIVO ,would be a nice place to start
The claims of the new patent protect Immutep’s intellectual property relating to combined therapeutic preparations comprising (a) its lead active EFT immunotherapy candidate addition to broader style claims, the granted claims include narrower claims drawn to specificand (b) an anti-PD-1 or anti-PD-L1 antibody. In combinations of efti with pembrolizumab, nivolumab,avelumab,durvalumab or atezolizumab The claims are also directed to related methods of use in the treatment of cancer.
You can dust those other patent’s down now Marc.OPDIVO ,would be...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 53192 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 41048 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |